{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:52:38Z","timestamp":1790689958930,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.bioorg.2020.103914","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T12:02:58Z","timestamp":1589198578000},"page":"103914","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Bioinformatic and biochemical findings disclosed anti-hepatic steatosis mechanism of calycosin"],"prefix":"10.1016","volume":"100","author":[{"given":"Xuebing","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hangyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2020.103914_b0005","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.gtc.2019.09.003","article-title":"Nutrition and nonalcoholic fatty liver disease: current perspectives","volume":"49","author":"Chakravarthy","year":"2020","journal-title":"Gastroenterol. Clin. North Am."},{"key":"10.1016\/j.bioorg.2020.103914_b0010","article-title":"Addressing the heterogeneity in liver diseases using biological networks","author":"Lam","year":"2020","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.bioorg.2020.103914_b0015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/jgh.12036","article-title":"Epidemiology of alcoholic and nonalcoholic fatty liver disease in China","volume":"28","author":"Fan","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bioorg.2020.103914_b0020","doi-asserted-by":"crossref","first-page":"131","DOI":"10.17235\/reed.2020.6640\/2019","article-title":"Metabolic syndrome, non-alcoholic fatty liver disease and hepatocarcinoma","volume":"112","author":"Serradilla Mart\u00edn","year":"2020","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"10.1016\/j.bioorg.2020.103914_b0025","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1093\/bib\/bbx144","article-title":"Precision medicine needs pioneering clinical bioinformaticians","volume":"20","author":"G\u00f3mez-L\u00f3pez","year":"2019","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.bioorg.2020.103914_b0030","first-page":"447","article-title":"Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment","volume":"111","author":"Wei\u00df","year":"2014","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.bioorg.2020.103914_b0035","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.chc.2014.05.011","article-title":"Traditional Chinese medicine in the treatment of ADHD: a review","volume":"23","author":"Ni","year":"2014","journal-title":"Child Adolesc. Psychiatr. Clin. N Am."},{"key":"10.1016\/j.bioorg.2020.103914_b0040","first-page":"1153","article-title":"In silico polypharmacology of natural products","volume":"19","author":"Fang","year":"2018","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.bioorg.2020.103914_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.111921","article-title":"Astragalus membranaceus (Huang Qi) as adjunctive therapy for diabetic kidney disease: An updated systematic review and meta-analysis","volume":"239","author":"Zhang","year":"2019","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.bioorg.2020.103914_b0050","doi-asserted-by":"crossref","first-page":"5589","DOI":"10.12659\/MSM.918250","article-title":"Discovery of the anti-tumor mechanism of calycosin against colorectal cancer by using system pharmacology approach","volume":"25","author":"Huang","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bioorg.2020.103914_b0055","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.phymed.2016.12.006","article-title":"Calycosin attenuates triglyceride accumulation and hepatic fibrosis in murine model of non-alcoholic steatohepatitis via activating farnesoid X receptor","volume":"25","author":"Duan","year":"2017","journal-title":"Phytomedicine"},{"key":"10.1016\/j.bioorg.2020.103914_b0060","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/jgh.13884","article-title":"Effects of calycosin against high-fat diet-induced nonalcoholic fatty liver disease in mice","volume":"33","author":"Duan","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bioorg.2020.103914_b0065","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.12659\/MSM.916662","article-title":"Pharmacological targets and the biological mechanisms of formononetin for Alzheimer's disease: a network analysis","volume":"25","author":"Xiao","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bioorg.2020.103914_b0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jare.2019.05.003","article-title":"To reveal pharmacological targets and molecular mechanisms of curcumol against interstitial cystitis","volume":"20","author":"Wu","year":"2019","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.bioorg.2020.103914_b0075","doi-asserted-by":"crossref","first-page":"103200","DOI":"10.1016\/j.etap.2019.103200","article-title":"Bioinformatic and experimental data decipher the pharmacological targets and mechanisms of plumbagin against hepatocellular carcinoma","volume":"70","author":"Zhou","year":"2019","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.103914_b0080","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/bib\/bbx125","article-title":"Web-based drug repurposing tools: a survey","volume":"20","author":"Sam","year":"2019","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.bioorg.2020.103914_b0085","doi-asserted-by":"crossref","first-page":"4648","DOI":"10.12659\/MSM.917240","article-title":"The effects of plumbagin on pancreatic cancer: a mechanistic network pharmacology approach","volume":"25","author":"Pan","year":"2019","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bioorg.2020.103914_b0090","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1093\/bib\/bby001","article-title":"Characteristics and evolution of the ecosystem of software tools supporting research in molecular biology","volume":"20","author":"Pazos","year":"2019","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.bioorg.2020.103914_b0095","doi-asserted-by":"crossref","first-page":"11265","DOI":"10.1002\/jcb.28404","article-title":"Anti-colorectal cancer targets of resveratrol and biological molecular mechanism: Analyses of network pharmacology, human and experimental data","volume":"120","author":"Li","year":"2019","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.bioorg.2020.103914_b0100","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/bib\/bbx091","article-title":"Pathway enrichment analysis approach based on topological structure and updated annotation of pathway","volume":"20","author":"Yang","year":"2019","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.bioorg.2020.103914_b0105","doi-asserted-by":"crossref","first-page":"6017","DOI":"10.1111\/jcmm.14464","article-title":"Lipidomic characteristics and clinical findings of epileptic patients treated with valproic acid","volume":"23","author":"Li","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bioorg.2020.103914_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2019.124810","article-title":"Metabolomic analysis reveals metabolic alterations of human peripheral blood lymphocytes by perfluorooctanoic acid","volume":"239","author":"Li","year":"2020","journal-title":"Chemosphere"},{"issue":"5","key":"10.1016\/j.bioorg.2020.103914_b0115","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1007\/s11356-017-0872-7","article-title":"Adverse bioeffect of perfluorooctanoic acid on liver metabolic function in mice","volume":"25","author":"Wu","year":"2018","journal-title":"Environ. Sci. Pollut. Res. Int."},{"key":"10.1016\/j.bioorg.2020.103914_b0120","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.etap.2018.12.004","article-title":"Hepatoprotective benefits of vitamin C against perfluorooctane sulfonate-induced liver damage in mice through suppressing inflammatory reaction and ER stress","volume":"65","author":"Su","year":"2019","journal-title":"Environ. Toxicol. Pharmacol."},{"key":"10.1016\/j.bioorg.2020.103914_b0125","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/biof.1519","article-title":"Potential biomarker of fibroblast growth factor 21 in valproic acid-treated livers","volume":"45","author":"Xu","year":"2019","journal-title":"Biofactors"},{"key":"10.1016\/j.bioorg.2020.103914_b0130","doi-asserted-by":"crossref","first-page":"16153","DOI":"10.1002\/jcb.28896","article-title":"Endocrinological characterization of pancreatic ducts in HFD and HGD fed mice","volume":"120","author":"Huang","year":"2019","journal-title":"J. Cell Biochem."},{"key":"10.1016\/j.bioorg.2020.103914_b0135","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1039\/C5FO00374A","article-title":"Calycosin induces apoptosis by the regulation of ER\u03b2\/miR-17 signaling pathway in human colorectal cancer cells","volume":"6","author":"Chen","year":"2015","journal-title":"Food Funct."},{"key":"10.1016\/j.bioorg.2020.103914_b0140","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1093\/bib\/bbx135","article-title":"A rank-based algorithm of differential expression analysis for small cell line data with statistical control","volume":"20","author":"Li","year":"2019","journal-title":"Brief Bioinform."},{"key":"10.1016\/j.bioorg.2020.103914_b0145","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bioorg.2020.103914_b0150","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1007\/s10620-016-4079-4","article-title":"Fibrosis assessment in nonalcoholic fatty liver disease (NAFLD) in 2016","volume":"61","author":"Kaswala","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.bioorg.2020.103914_b0155","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.gtc.2016.07.003","article-title":"Nonalcoholic fatty liver disease: pathophysiology and management","volume":"45","author":"Carr","year":"2016","journal-title":"Gastroenterol. Clin. North Am."},{"key":"10.1016\/j.bioorg.2020.103914_b0160","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13046-017-0625-y","article-title":"Calycosin inhibits the in vitro and in vivo growth of breast cancer cells through WDR7-7-GPR30 Signaling","volume":"36","author":"Tian","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bioorg.2020.103914_b0165","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2174\/1386207322666190411112814","article-title":"Effect of Chinese herbal monomer hairy calycosin on nonalcoholic fatty liver rats and its mechanism","volume":"22","author":"Liu","year":"2019","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"10.1016\/j.bioorg.2020.103914_b0170","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1111\/acer.13904","article-title":"Alcohol dehydrogenases, aldehyde dehydrogenases, and alcohol use disorders: a critical review","volume":"42","author":"Edenberg","year":"2018","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.bioorg.2020.103914_b0175","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.jhep.2014.10.009","article-title":"Aldehyde dedydrogenase-2 plays a beneficial role in ameliorating chronic alcohol-induced hepatic steatosis and inflammation through regulation of autophagy","volume":"62","author":"Guo","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bioorg.2020.103914_b0180","doi-asserted-by":"crossref","unstructured":"C. Enrich, C. Rentero, T. Grewal, C.E. Futter, E.R. Eden, Cholesterol Overload: Contact Sites to the Rescue! Contact (Thousand Oaks) 2 (2019) 2515256419893507.","DOI":"10.1177\/2515256419893507"},{"key":"10.1016\/j.bioorg.2020.103914_b0185","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1210\/er.2017-00176","article-title":"The extending spectrum of NPC1-related human disorders: from Niemann-Pick C1 disease to obesity","volume":"39","author":"Lamri","year":"2018","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bioorg.2020.103914_b0190","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1080\/14728222.2018.1439924","article-title":"Extracellular HMGB1 as a therapeutic target in inflammatory diseases","volume":"22","author":"Andersson","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bioorg.2020.103914_b0195","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.jhep.2013.03.033","article-title":"Decoding cell death signals in liver inflammation","volume":"59","author":"Brenner","year":"2013","journal-title":"J. Hepatol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820306544?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820306544?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:04:10Z","timestamp":1758614650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820306544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":39,"alternative-id":["S0045206820306544"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103914","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bioinformatic and biochemical findings disclosed anti-hepatic steatosis mechanism of calycosin","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.103914","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103914"}}